白念珠菌唑类耐药和生物膜相关基因的表达

doi:10.3969/j.issn.1673-8640.2014.06.005

检验医学 ›› 2014, Vol. 29 ›› Issue (6): 597-602.DOI: 10.3969/j.issn.1673-8640.2014.06.005

白念珠菌唑类耐药和生物膜相关基因的表达

胡绿荫¹,宰淑蓓¹,金鑫¹,蔡金凤¹,曹宇硕¹,胡香南¹,杜昕²,李天铭²,李敏³

1. 上海市(复旦大学附属)公共卫生临床中心医学检验科,上海 201508;
2. 复旦大学附属华山医院检验科,上海 200040;
3. 上海交通大学医学院附属仁济医院检验科,上海 200127

收稿日期:2014-01-04 出版日期:2014-06-30 发布日期:2014-06-23
通讯作者: 李敏,联系电话:021-52888323。
作者简介:胡绿荫,女,1984年生,学士,主管技师,主要从事白念珠菌流行病学和耐药机制研究。
基金资助:
国家自然科学基金资助项目(81171623, 81261120387, 81322025, 81371875);上海优秀青年人才培养计划项目(XYQ2011039);上海曙光人才计划(12SG03)

The expression of genes related to azole resistance and biofilm in Candida albicans

HU Lüyin¹, ZAI Shubei¹, JIN Xin¹, CAI Jinfeng¹, CAO Yushuo¹, HU Xiangnan¹, DU Xin², LI Tianming², LI Min³

1. Department of Clinical Laboratory, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China;
2. Department of Clinical Laboratory, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China;
3. Department of Clinical Laboratory, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China

Received:2014-01-04 Online:2014-06-30 Published:2014-06-23

摘要/Abstract

摘要：

目的研究白念珠菌临床分离株唑类耐药和生物膜形成相关基因的表达。方法收集上海市公共卫生临床中心2006至2011年92例感染性疾病患者[病毒性肝炎、结核、获得性免疫缺陷综合征(AIDS)] 血液、无菌部位和黏膜分离鉴定的白念珠菌104株,选用ATB FUNGUS3检测抗菌药物(氟康唑、伊曲康唑和伏立康唑)的最低抑菌浓度(MIC),采用半定量逆转录聚合酶链反应(PCR)分析唑类敏感、浓度依赖性敏感(S-DD)和耐药菌株之间药物外排泵基因CDR1、CDR2、MDR1和药物靶酶基因ERG11表达的差异,同时通过甲基四氮盐(XTT)代谢试验筛选强生物膜形成能力菌株(HBFs),研究其与弱生物膜形成能力菌株(LBFs)相关基因ALS3和HWP1表达的差异。结果 104株白念珠菌中共检测出16株至少对1种唑类药物耐药,6株至少对1种唑类药物S-DD。药物靶酶基因ERG11在耐药株、S-DD株和敏感菌之间比较,差异有统计学意义(P=0.007 8),且耐药株、S-DD株分别与敏感菌比较,差异有统计学意义(P<0.05),然而CDR1、CDR2和MDR1表达量在3种菌株间无明显差异。生物膜形成能力试验显示16株菌生物膜形成能力增强,其HWP1表达量与LBFs比较差异有统计学意义(P=0.007 9),ALS3表达量差异无统计学意义。结论 ERG11基因的过度表达为白念珠菌唑类耐药的重要机制。菌丝细胞壁蛋白HWP1基因的高表达与白念珠菌生物膜形成增强相关。

关键词: 外排泵, ERG11, 生物膜, 白念珠菌

Abstract:

Objective To investigate the expression of genes related to azole resistance and biofilm formation capability in clinical isolates of Candida albicans. Methods In this study, 104 Candida albicans were isolated from blood, sterile sites and mucosal lesions of 92 infectious disease patients [viral hepatitis, tuberculosis and acquired immune deficiency syndrome (AIDS) in Shanghai Public Health Clinical Center from 2006 to 2011. The minimum inhibitory concentrations (MICs) of fluconazole, itraconazole and voriconazole were determined by ATB FUNGUS3. The gene expression of efflux pump genes (CDR1, CDR2 and MDR1) and azole antifungal target gene ERG11 were determined by semi-quantitative reverse transcription polymerase chain reaction (PCR), and the azole susceptibe and susceptible dose dependent (S-DD) states were analyzed. 2,3-bis-(2-methoxy-4-nitro-5-sulphenyl)-2H-tetrazolium- 5-carboxanilide (XTT) test was used to screen the high biofilm formation capability isolates (HBPs). The expressions of ALS3 and HWP1 in low biofilm formation capability isolates (LBPs) were analyzed. Results Among 104 isolates of Candida albicans, 16 isolates were tested resistant to at least one azole, 6 isolates were S-DD to at least one azole.There were statistical significance among resistant, S-DD and susceptible isolates in azole antifungal target gene ERG11 (P=0.007 8), and significant difference was found when comparing susceptible isolates with resistant and S-DD ones (P<0.05). No significant difference was found in the expression levels of efflux pump genes, CDR1, CDR2 and MDR1. The expression levels of HWP1 in HBFs were higher than those in LBFswith statistical significance (P=0.007 9), whereas ALS3 showed nostatistical significance. Conclusions The overexpression levels of ERG11 gene may primarily account for resistance to azole in Candida albicans. High expression of hyphal wall protein HWP1 gene is associated to biofilm formation capability in Candida albicans.

Key words: Efflux pump, ERG11, Biofilm, Candida albicans

中图分类号:

R446.5

胡绿荫,宰淑蓓,金鑫,蔡金凤,曹宇硕,胡香南,杜昕,李天铭,李敏. 白念珠菌唑类耐药和生物膜相关基因的表达[J]. 检验医学, 2014, 29(6): 597-602.

HU Lüyin, ZAI Shubei, JIN Xin, CAI Jinfeng, CAO Yushuo, HU Xiangnan, DU Xin, LI Tianming, LI Min. The expression of genes related to azole resistance and biofilm in Candida albicans[J]. , 2014, 29(6): 597-602.

参考文献

[1] Kim J, Sudbery P. Candida albicans, a major human fungal pathogen[J] . J Microbiol,2011,49(2):171-177.
[2] Guo F, Yang Y, Kang Y, et al. Invasive candidiasis in intensive care units in China: a multicentre prospective observational study[J] . J Antimicrob Chemother,2013,68(7):1660-1668.
[3] Rosenblatt HM, Byrne W, Ament ME, et al. Successful treatment of chronic mucocutaneous candidiasis with ketoconazole[J] . J Pediatr,1980,97(4):657-660.
[4] Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi[J] . Lancet,2002,359(9312):1135-1144.
[5] Sanglard D, Kuchler K, Ischer F, et al. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters[J] . Antimicrob Agents Chemother,1995,39(11):2378-2386.
[6] Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences[J] . Lancet Infect Dis,2002,2(2):73-85.
[7] Xiang MJ, Liu JY, Ni PH, et al. Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans[J] . FEMS Yeast Res,2013,13(4):386-393.
[8] 项明洁,倪培华,刘锦燕,等. ERG11基因突变与白念珠菌对氟康唑耐药性的初步研究[J] . 检验医学,2009,24(12):856-860.
[9] D′Enfert C. Biofilms and their role in the resistance of pathogenic Candida to antifungal agents[J] . Curr Drug Targets,2006,7(4):465-470.
[10] Seneviratne CJ, Jin LJ, Samaranayake YH, et al. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms[J] . Antimicrob Agents Chemother,2008,52(9):3259-3266.
[11] Perea S. Azole resistance in Candida albicans[J] . Rev Esp Quimioter,2000,13(3):314-317.
[12] Basso LJ Jr, Gast CE, Mao Y, et al. Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p[J] . Eukaryot Cell,2010,9(6):960-970.
[13] 江岑,董丹凤,俞焙秦,等. 3种念珠菌对氟康唑耐药的易感性及耐药机制比较[J] . 中国感染与化疗杂志,2013, 13(4):296-301.
[14] Nailis H, Vandenbroucke R, Tilleman K, et al. Monitoring ALS1 and ALS3 gene expression during in vitro Candida albicans biofilm formation under continuous flow conditions[J] . Mycopathologia,2009,167(1):9-17.
[15] Nobile CJ, Nett JE, Andes DR, et al. Function of Candida albicans adhesin Hwp1 in biofilm formation[J] . Eukaryot Cell,2006,5(10):1604-1610.

白念珠菌唑类耐药和生物膜相关基因的表达

The expression of genes related to azole resistance and biofilm in Candida albicans

RichHTML

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	张亚茹, 凌丽燕, 陈敏. EUCAST和CLSI微量肉汤稀释法白念珠菌体外药物敏感性试验结果比较[J]. 检验医学, 2022, 37(10): 974-978.
[2]	李贞, 殷红梅, 陈伟琴, 薛赢俊, 胡骏, 诸斌, 胡晓波. 土槿皮乙酸与氟康唑联合应用于体外抗白念珠菌活性研究[J]. 检验医学, 2020, 35(7): 663-667.
[3]	孙康德, 张家胜, 陈旭, 虞中敏, 陈福祥. 口腔白念珠菌耐药性及毒力因子表达水平相关性研究[J]. 检验医学, 2019, 34(8): 730-735.
[4]	徐炜新, 孙杰. 多位点序列分析法在白念珠菌性阴道炎唑类耐药菌株分子流行病学研究中的运用[J]. 检验医学, 2018, 33(3): 233-238.
[5]	王敬华, 虞培娟, 葛平, 徐蓉, 陈蓉, 刘学杰, 王华梁. 不对称荧光PCR扩增白念珠菌ITS-2基因单链DNA实验[J]. 检验医学, 2017, 32(3): 210-213.
[6]	孙康德, 陈铖, 陈旭, 张家胜, 虞中敏, 陈福祥. 口腔白念珠菌耐药性与基因分型及耐药基因表达的分析[J]. 检验医学, 2017, 32(11): 979-984.
[7]	赵虎. 深部真菌的耐药性及其耐药机制研究[J]. 检验医学, 2016, 31(9): 735-738.
[8]	吴永琴, 应春妹. 白念珠菌唑类药物相关耐药基因及其调控机制的研究进展[J]. 检验医学, 2016, 31(9): 739-743.
[9]	王影, 张嵘, 刘锦燕, 史册, 李文静, 赵悦, 项明洁. 白念珠菌MRR2基因错义突变C1409A与氟康唑耐药的相关性[J]. 检验医学, 2016, 31(9): 744-749.
[10]	孙康德, 张家胜, 陈旭, 虞中敏, 陈福祥. 口腔白念珠菌3种致病相关分泌型水解酶检测方法的建立及应用[J]. 检验医学, 2016, 31(5): 355-358.
[11]	李文静, 沈韻, 刘锦燕, 史册, 王影, 赵悦, 项明洁. 转录因子Flo8 G723R、T751D突变增强白念珠菌毒力[J]. 检验医学, 2016, 31(11): 987-992.
[12]	黄声雷, 胡必杰, 陈蓉, 周春妹. 两种MALDI-TOF MS系统快速鉴定血培养中白念珠菌以外酵母样真菌[J]. 检验医学, 2015, 30(2): 128-131.
[13]	张广慧, 曹雪萍, 俞静, 刘瑛, 葛艳. 耐碳青霉烯鲍曼不动杆菌临床分离株的流行病学与耐药机制研究[J]. 检验医学, 2015, 30(1): 53-57.
[14]	魏冰,刘锦燕,史册,项明洁. 白念珠菌对唑类药物耐药机制的研究进展[J]. 检验医学, 2014, 29(9): 978-981.
[15]	何力志, 石国民, 胡方兴. 1,3-β-D-葡聚糖和抗白念珠菌芽管抗体检测对侵袭性念珠菌病诊断的临床价值[J]. 检验医学, 2014, 29(8): 794-797.